ARCHIVES

Hybridoma Cell Lines Available from NCI

This article is from The Cancer Letter archive.

Vol. 08 No. 34 | September 3, 1982

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Broder Explains Where R01 Money Has Gone

July 20, 1990